84 related articles for article (PubMed ID: 7162464)
1. Enzymology of cytosine arabinoside.
Cheng YC; Capizzi RL
Med Pediatr Oncol; 1982; 10 Suppl 1():27-31. PubMed ID: 7162464
[No Abstract] [Full Text] [Related]
2. Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.
Chabot GG; Bouchard J; Momparler RL
Biochem Pharmacol; 1983 Apr; 32(7):1327-8. PubMed ID: 6189497
[No Abstract] [Full Text] [Related]
3. Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
Mejer J; Mortensen BT
Adv Exp Med Biol; 1989; 253B():335-9. PubMed ID: 2558539
[No Abstract] [Full Text] [Related]
4. Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia.
Colly LP; Peters WG; Richel D; Arentsen-Honders MW; Starrenburg CW; Willemze R
Semin Oncol; 1987 Jun; 14(2 Suppl 1):257-61. PubMed ID: 3035720
[TBL] [Abstract][Full Text] [Related]
5. Deamination rates of 1-beta-D-arabinofuranosylcytosine, deoxycytidine and 5-methyl-2'-deoxycytidine in seven hematopoietic cell lines.
Jekunen A
Med Biol; 1987; 65(4):203-8. PubMed ID: 3437781
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and substrate specificity of human and canine cytidine deaminase.
Fanucchi MP; Watanabe KA; Fox JJ; Chou TC
Biochem Pharmacol; 1986 Apr; 35(7):1199-201. PubMed ID: 3964296
[No Abstract] [Full Text] [Related]
7. In vivo development of cytosine arabinoside resistance in the BN acute myelocytic leukemia.
Hagenbeek A; Martens AC; Colly LP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):202-6. PubMed ID: 3473677
[TBL] [Abstract][Full Text] [Related]
8. Effect of cytosine arabinoside metabolizing enzyme expression on drug toxicity in acute myeloid leukemia.
Abraham A; Devasia AJ; Varatharajan S; Karathedath S; Balasubramanian P; Mathews V
Ann Hematol; 2015 May; 94(5):883-5. PubMed ID: 25391240
[No Abstract] [Full Text] [Related]
9. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
10. Alkylated cytosine nucleosides: substrate and inhibitor properties in enzymatic deamination.
Krajewska E; Shugar D
Acta Biochim Pol; 1975; 22(2):185-94. PubMed ID: 1098340
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic studies on possible improvement of cytosine arabinoside treatment.
Mejer J
Scand J Clin Lab Invest; 1981 Feb; 41(1):29-34. PubMed ID: 6942484
[TBL] [Abstract][Full Text] [Related]
12. Deoxycytidine kinase and cytosine nucleoside deaminase activities in synchronized cultures of normal rat kidney cells.
Wan CW; Mak TW
Cancer Res; 1978 Sep; 38(9):2768-72. PubMed ID: 679182
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of cytosine arabinoside in Tetrahymena pyriformis.
Benhura MA
Comp Biochem Physiol B; 1985; 80(4):821-5. PubMed ID: 3922672
[TBL] [Abstract][Full Text] [Related]
14. Studies on mechanisms of resistance to cytosine arabinoside: problems in the determination of related enzyme activities in leukemic cells.
Coleman CN; Johns DG; Chabner BA
Ann N Y Acad Sci; 1975 Aug; 255():247-51. PubMed ID: 171992
[No Abstract] [Full Text] [Related]
15. Pyrimidine pathways enzymes in human tumors of brain and associated tissues: potentialities for the therapeutic use of N-(phosphonacetyl-L-aspartate and 1-beta-D-arabinofuranosylcytosine.
Madani S; Baillon J; Fries J; Belhadj O; Bettaieb A; Ben Hamida M; Hervé G
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1485-90. PubMed ID: 2824206
[TBL] [Abstract][Full Text] [Related]
16. In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-AZA-2'-deoxycytidine.
Onetto N; Momparler RL; Momparler LF; Gyger M
Semin Oncol; 1987 Jun; 14(2 Suppl 1):231-7. PubMed ID: 2438776
[No Abstract] [Full Text] [Related]
17. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
Ohta T; Hori H; Ogawa M; Miyahara M; Kawasaki H; Taniguchi N; Komada Y
Oncol Rep; 2004 Nov; 12(5):1115-20. PubMed ID: 15492802
[TBL] [Abstract][Full Text] [Related]
18. The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.
Mancini WR
Cancer Chemother Pharmacol; 1992; 30(2):139-44. PubMed ID: 1318170
[TBL] [Abstract][Full Text] [Related]
19. Modulation of metabolism of cytosine arabinoside in L cells by antibody and complement.
Shearer WT; Green CG; Mettes HJ
Immunopharmacology; 1983 Oct; 6(3):203-14. PubMed ID: 6629738
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines.
Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Peters GJ
Adv Exp Med Biol; 1994; 370():139-43. PubMed ID: 7660877
[No Abstract] [Full Text] [Related]
[Next] [New Search]